Literature DB >> 35265404

Human Cytomegalovirus Seroprevalence Among Blood Donors in the Madinah Region, Saudi Arabia.

Waleed Mahallawi1, Omar F Khabour2, Abdullah Al-Saedi1, Ziyad Almuzaini1, Nadir Ibrahim1.   

Abstract

Background and objective Human cytomegalovirus (HCMV), a double-stranded DNA virus of the Herpesviridae family, can remain latent for long periods of time. HCMV may cause severe illness in immunocompromised patients and is associated with congenital anomalies. This study aimed to determine the anti-HCMV immunoglobulin G (IgG) and IgM antibody seroprevalence among blood-donating Saudi men in the Madinah region. Methods A total of 375 blood-donating Saudi men were recruited from the Central Blood Bank in Madinah, the Kingdom of Saudi Arabia (KSA), and stratified into three age groups: 18-30, 31-40, and 41-61 years. Anti-HCMV IgG and IgM antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Pearson's correlation coefficient was used to correlate antibody levels with variables. Results Most of the tested samples (95.73%, n=356) were positive for anti-HCMV IgG antibodies, but only 1.6% (n=6) were positive for both IgM and IgG antibodies, and all of them belonged to the age groups of 31-40 and 41-61 years. A strong inverse correlation was found between anti-HCMV IgG antibody levels and age (r=-0.51, p<0.0001). Additionally, there was an inverse correlation between anti-HCMV IgG antibody levels and body mass index (BMI) (r=-0.11, p=0.036). No correlations were found between anti-HCMV IgG levels and hemoglobin levels or blood groups of the participants. Conclusions Blood-donating Saudi men in Madinah had a high seroprevalence of anti-HCMV IgG antibodies, indicating previous viral exposure. Age and BMI might influence the humoral immunologic memory response against HCMV, which appears to be endemic in Madinah.
Copyright © 2022, Mahallawi et al.

Entities:  

Keywords:  blood donors; hcmv; immunocompromised; madinah; seroprevalence

Year:  2022        PMID: 35265404      PMCID: PMC8897812          DOI: 10.7759/cureus.21860

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  42 in total

1.  Cytomegalovirus seroprevalence and 'cytomegalovirus-safe' seropositive blood donors.

Authors:  K G Badami; S McQuilkan-Bickerstaffe; J E Wells; M Parata
Journal:  Epidemiol Infect       Date:  2009-06-01       Impact factor: 2.451

2.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

3.  Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation.

Authors:  Amit Kalra; Tyler Williamson; Andrew Daly; M Lynn Savoie; Douglas A Stewart; Faisal Khan; Jan Storek
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-28       Impact factor: 5.742

4.  Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.

Authors:  Elin Bernson; Alexander Hallner; Frida E Sander; Malin Nicklasson; Malin S Nilsson; Karin Christenson; Ebru Aydin; Jan-Åke Liljeqvist; Mats Brune; Robin Foà; Johan Aurelius; Anna Martner; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  Cancer Immunol Res       Date:  2018-07-06       Impact factor: 11.151

5.  The prevalence of human cytomegalovirus seropositivity among blood donors at the Unit of Blood Transfusion Medicine, Hospital Universiti Sains Malaysia.

Authors:  S A Ahmed; F S Al-Joudi; A Wan Zaidah; T M Roshan; M Rapiaah; Y M S Abdullah; H Rosline
Journal:  Southeast Asian J Trop Med Public Health       Date:  2006-03       Impact factor: 0.267

6.  Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.

Authors:  Mohamed Zuhair; G Suzanne A Smit; Gabriel Wallis; Faiz Jabbar; Colette Smith; Brecht Devleesschauwer; Paul Griffiths
Journal:  Rev Med Virol       Date:  2019-01-31       Impact factor: 6.989

7.  CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.

Authors:  Fredrik Sund; Anna-Karin Lidehäll; Kerstin Claesson; Aksel Foss; Thomas H Tötterman; Olle Korsgren; Britt-Marie Eriksson
Journal:  Clin Transplant       Date:  2009-02-14       Impact factor: 2.863

8.  Seroprevalence of Human Cytomegalovirus in Pregnant Women in the Asir Region, Kingdom of Saudi Arabia.

Authors:  Mohammed K Almaghrabi; Ali Dafer Alwadei; Nawaf M Alyahya; Fadaa M Alotaibi; Ahmad Hussain Alqahtani; Khalid A Alahmari; Mohammad Salem Alqahtani; Ahmad Saeed Alayed; Riyad Moosa; Abdelwahid S Ali
Journal:  Intervirology       Date:  2020-03-24       Impact factor: 1.763

9.  Obesity, Metabolic Health, and History of Cytomegalovirus Infection in the General Population.

Authors:  Mark Hamer; G David Batty; Mika Kivimäki
Journal:  J Clin Endocrinol Metab       Date:  2016-02-10       Impact factor: 5.958

10.  Acute human cytomegalovirus infection among voluntary blood donors in the Lake Victoria zone blood transfusion centre: should it be considered in screening?

Authors:  Erius Tebuka; Ruharara D Fulgence; Bertrand Msemwa; Vitus Silago; Stephen E Mshana; Mariam M Mirambo
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.